AstraZeneca, Eledon and Alpine spell out kidney program successes: ASN roundupnews2023-11-06T12:06:01+00:00November 6th, 2023|Endpoints News|
Bristol Myers buys Orum Therapeutics’ protein degrader take on ADCs for $100M upfrontnews2023-11-06T12:00:43+00:00November 6th, 2023|Endpoints News|
Starton Therapeutics calls off SPAC merger with Healthwell Acquisition Corpnews2023-11-06T11:36:06+00:00November 6th, 2023|Endpoints News|
Latest news on BioNTech’s Friday buyout; Unpacking Sarepta’s Duchenne data; Pfizer’s post-Covid plans; Eli Lilly, AstraZeneca’s gene editing deals; and morenews2023-11-04T10:00:22+00:00November 4th, 2023|Endpoints News|
House Oversight Committee opens probe into FDA’s handling of drug shortagesnews2023-11-03T18:52:07+00:00November 3rd, 2023|Endpoints News|
BIO, PhRMA press FDA for concrete details on new IT strategynews2023-11-03T18:45:48+00:00November 3rd, 2023|Endpoints News|
FDA hands India’s Natco Pharma another 483, with eight observations cited news2023-11-03T18:13:47+00:00November 3rd, 2023|Endpoints News|
BioNTech acquires lipid nanoparticle startup founded by George Mason and UPenn scientistsnews2023-11-03T17:18:03+00:00November 3rd, 2023|Endpoints News|
What’s fair: ICER report finds insurer coverage typically meets access criteria for 18 prescription drugsnews2023-11-03T17:10:15+00:00November 3rd, 2023|Endpoints News|
Pfizer to cut 200 jobs at Michigan plant that makes Covid productsnews2023-11-03T16:39:10+00:00November 3rd, 2023|Endpoints News|
